HangZhou Fanttest Biotech Co,. Ltd.
HangZhou Fanttest Biotech Co,. Ltd.

Zika NS1 Rapid Test Cassette

It is spread by daytimeactive A edes mosquitoes, such asA. aegypti and A. albopictus. Zika virus is related to the dengue, yellow fever, Japanese encephalitis, and West Nile viruses. The infection, known as Zika fever or Zika virus disease, often causes no or only mild symptoms, similar to a very mild form of dengue fever. Zika can also spread from a pregnant woman to her fetus. This can result in microcephaly, severe brain malformations, and other birth defects. Zika infections in adults may result rarely in Guillain–Barré syndrome.

Contact Us
Background Intended Use Operation

Zika NS1 Rapid Test Cassette Product Background

Zika virus (ZIKV) is a member of the virus family Flaviviridae. It is spread by daytimeactive A edes mosquitoes, such asA. aegypti and A. albopictus. Its name comes from the Zika Forest of Uganda, where the virus was first isolated in 1947. Zika virus is related to the dengue, yellow fever, Japanese encephalitis, and West Nile viruses. Since the 1950s, it has been known to occur within a narrow equatorial belt from Africa to Asia. From 2007 to 2016, the virus spread eastward, across the Pacific Ocean to the Americas, leading to the 2015–16 Zika virus epidemic.


The infection, known as Zika fever or Zika virus disease, often causes no or only mild symptoms, similar to a very mild form of dengue fever. While there is no specific treatment, paracetamol (acetaminophen) and rest may help with the symptoms. As of 2016, the illness cannot be prevented by medications or vaccines. Zika can also spread from a pregnant woman to her fetus. This can result in microcephaly, severe brain malformations, and other birth defects. Zika infections in adults may result rarely in Guillain–Barré syndrome.


View More View Less

Zika NS1 Rapid Test Cassette Intended Use

The Zika NS1 Rapid Test Kit is a rapid chromatographic immunoassay for the qualitative detection of Zika virus NS1 antigen in human whole blood, serum, or plasma. As an aid in the diagnosis of primary and secondary Zika infections.

View More View Less

Zika NS1 Rapid Test Cassette Operation Steps And Result Interpretation

  • POSITIVE: Two distinct colored lines appear.One color line should be in the control region (C) and another color line should be in the test region (T). *NOTE: The intensity of the color in the test line region (T) will vary depending on the concentration of Dengue NS1 antigen present in the specimen. Therefore, any shade of red in the test region should be considered positive.

  • NEGATIVE: One color line appears in the control region (C).No apparent red or pink line appears in the test region (T).

  • INVALID: Control line fails to appear. Insufficient specimen volume or incorrect procedural techniques are the most likely reasons for control line failure. Review the procedure and repeat the test with a new test. If the problem persists discontinue using the test kit immediately and contact your local distributor.

View More View Less
Please Contact Us
Please Contact Us

To monitor your health status anytime, anywhere and achieve self-inspection and self-testing.

06/16
2025
Fanttest Biotech's H. pylori Product Approved by Hong Kong Department of Health!
On April 30, 2025, Hangzhou Fanttest Biotech (hereinafter referred to as “Fanttest”) announced that its independently developed Helicobacter pylori (H. pylori) diagnostic product has successfully pa...
06/13
2025
COVID Is Still Around and a Risk to Susceptible People. What Are the Symptoms in 2025?
Most people who contract COVID today will only experience mild symptoms. However, some individuals remain at risk of severe illness and are more likely to be hospitalised. This includes older adults, ...
04/21
2025
Congratulation!! Fanttest's 6-in-1 and 8-in-1 Respiratory Infectious Diseases Combination Test Kits Has Obtained Authoritative Certification From Hong Kong Department of Health!
On April 14, 2025, Hangzhou Fanttest Biotech Co., Ltd. (hereinafter referred to as "Fanttest") announced that its independently developed rapid respiratory diseases combination test kits (6-...